Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(13):947; doi:10.1093/jnci/dji220
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Japanese Translation
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Inflammatory Breast Cancer Incidence and Survival

Inflammatory breast cancer (IBC) appears to be a distinct subtype of breast cancer different from non-inflammatory locally advanced breast cancer (LABC). To investigate incidence and survival trends for IBC, non-T4 breast cancer, and LABC, Hance et al. (p. 966) examined 180,224 female breast cancer cases reported to the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) cancer registries from 1988 through 2000. Incidence rates of IBC increased, whereas incidence rates of LABC and non-T4 breast cancer decreased over the same study period. Despite modest improvements in survival throughout the 1990s, women diagnosed with . . . [Full Text of this Article]

Employment Outcomes of Men Treated for Prostate Cancer

Aspirin, Other NSAIDs, and Prostate Cancer Risk

k-ras, b-raf, and p53 Status and Bevacizumab Response

Flexible Sigmoidoscopy Acceptance in a Clinical Trial

MC1R, ASIP, and DNA Repair and Melanoma Risk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?